Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00406913 · ClinicalTrials.gov registry record · NA

Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery

A NA study of Cataract Surgery and Prophylaxis, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT00406913 is a NA study of Cataract Surgery and Prophylaxis that has completed, run by University of Chicago. The registered enrollment target is 37 participants, below the 141-participant average among 7 other Cataract Surgery trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00406913, a NA study of Cataract Surgery and Prophylaxis, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the conjunctival flora prior to cataract or vitrectomy surgery comparing mupirocin ointment applied to the conjunctiva along with standard ocular sterilization vs. standard ocular sterilization alone.

Interventions

  • DRUG mupirocin ointment
  • OTHER SOC sterilization

Study Locations (1)

Illinois

  • University of Chicago Hospitals - Chicago

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2005-10
Est. Completion 2006-11
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT00406913

The ClinicalTrials.gov registry entry for NCT00406913 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 7 other Cataract Surgery trials with a reported enrollment target (74% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cataract Surgery appearing as the primary indexed condition, and to 2 interventions - of which mupirocin ointment is the first listed.

NCT00406913 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00406913 about?

NCT00406913 is a clinical study titled "Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery". The purpose of this study is to evaluate the conjunctival flora prior to cataract or vitrectomy surgery comparing mupirocin ointment applied to the conjunctiva along with standard ocular sterilization vs. standard ocular sterilization alone.

What is the current status of trial NCT00406913?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2005-10. Estimated completion is 2006-11.

What conditions does trial NCT00406913 study?

This clinical trial studies the following conditions: Cataract Surgery, Prophylaxis, Endophthalmitis.

What interventions are being tested in trial NCT00406913?

The interventions under investigation include: mupirocin ointment (DRUG), SOC sterilization (OTHER).

Who is sponsoring clinical trial NCT00406913?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00406913 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.